Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Puerariae Lobatae Radix can reduce sebaceous gland size and secretion, potentially treating related skin conditions.

Enhanced stem cells from the placenta can help treat Graves' eye disease by stopping fat cell growth.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

Androgen receptors in the brain affect metabolism and reproduction differently in males and females, and may help manage PCOS symptoms in females.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

A new treatment for hair loss shows promise with fewer side effects.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Bimatoprost treats glaucoma and promotes hair growth, with potential for more medical uses.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

A cream with a specific hormone blocker increases hair growth in mice.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Blocking DPP4 can help activate hair growth and improve hair regeneration.

DPP may help hair regrowth by improving blood vessel function under stress.

The diphosphonate was the most effective at preventing calcification in rats.

Enhanced stem cells from the placenta can reduce fat buildup in eye tissue for Graves' disease.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Targeting the PGD2-DP2 pathway may help treat hair loss.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Pioglitazone combined with metformin or spironolactone improves PCOS symptoms and insulin resistance.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

New steroids were effective in blocking male hormone receptors in hamster prostates.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.